Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 24, 1997

View Archived Issues

Company Profile: Sibia Neurosciences

Bristol-Myers Squibb announces plans to double new product launches, overviews pipeline

Scherer, Elan extend Zydis selegiline licensing agreement

Cytel initiates registration trials of Cylexin in newborns

Apligraf scheduled for FDA advisory panel review

Procter & Gamble's COX-2 inhibitor in preclinical testing

RD4-6250: a potential new treatment for HCV

HNE inhibitors prepared at Glaxo Wellcome

Tanabe Seiyaku claims new PAI-1 inhibitors

Jouveinal patents PDE IV inhibitors

Peptidomimetic protein farnesyltransferase inhibitors in development at Merck

New antibacterial agent discovered by Sankyo

ACAT and lipid peroxidation inhibitors prepared at Tanabe Seiyaku

CCK-A antagonists revealed by Tobishi

Mitsui presents new antipsychotic agent

New AVP(4-9) analogue with beneficial effects on cognitive/memory deficits

Bayer/Genzyme drug discovery collaboration

Boehringer Ingelheim to develop and market Procysteine in Japan

Teijin starts clinical trials of in-licensed antiasthmatic drug

Neurogen updates its NPY program for obesity

BLA filed for palivizumab

Enzo's HIV gene therapy nears clinical testing

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...